Market Cap $ M 7.83
Enterprise Value $ M 6.54
P/E(ttm) --
PE Ratio without NRI --
Forward PE Ratio --
Price/Book --
Price/Sales 2.07
Price/Free Cash Flow --
Price/Owner Earnings --
Payout Ratio % --
Revenue (TTM) $ M --
EPS (TTM) $ -65.18
Beneish M-Score 0
10-y EBITDA Growth Rate % --
5-y EBITDA Growth Rate % 46.90
y-y EBITDA Growth Rate % --
EV-to-EBIT -0.32
EV-to-EBITDA -0.32
PEG --
Shares Outstanding M 1.58
Net Margin (%) -3,552.81
Operating Margin % -4,014.91
Pre-tax Margin (%) -3,552.81
Quick Ratio 0.57
Current Ratio 0.57
ROA % (ttm) -457.22
ROE % (ttm) -10,227.78
ROIC % (ttm) -2,037.85
Dividend Yield % --
Altman Z-Score -149.36
Piotroski F-Score 3.00
Positive ROA N
Positive CFROA N
Higher ROA y-y N
Cash flow > Earnings Y
Lower Leverage y-y Y
Higher Current Ratio y-y N
Less Shares Outstanding y-y N
Gross Margin Increase y-y N
Higher Asset Turnover y-y Y

VCNX Number of Guru Trades

To

VCNX Volume of Guru Trades

To

Gurus Latest Trades with NAS:VCNX

No Available Data

NAS:VCNX is held by these investors

No Available Data

Vaccinex Inc Insider Transactions

No Available Data

News about NAS:VCNX

Total 0
  • 1